echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Saving the lives of severe COVID-19 patients WHO recommends IL-6 receptor inhibitors

    Saving the lives of severe COVID-19 patients WHO recommends IL-6 receptor inhibitors

    • Last Update: 2021-08-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A few days ago, the World Health Organization (WHO) updated its COVID-19 patient care guidelines to include interleukin-6 (IL-6) receptor inhibitors


    The WHO press release stated that this is the first drug found to be effective against COVID-19 since the organization recommended corticosteroids in September 2020


    Severe or critical COVID-19 patients often have an overreaction of the immune system, which is very harmful to the health of the patient


    This data analysis shows that compared with standard treatment, the use of these drugs can reduce the chance of death by 13% in severe or critically ill patients


    Note: The original text has been deleted

    Reference materials:

    [1] WHO recommends life-saving interleukin-6 receptor blockers for COVID-19 and urges producers to join efforts to rapidly increase access.


    [2] Interleukin-6 Inhibitors.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.